Scotland Backed Amalgamation of Opdivo & Cabometryx for Treatment of Advanced Renal Carcinoma
Key Points – SMC approved Combination of Opdivo (Nivolumab) plus Cabometryx (Cabozantinib) for treatment of Advanced Renal Carcinoma In a Phase III…
Key Points – SMC approved Combination of Opdivo (Nivolumab) plus Cabometryx (Cabozantinib) for treatment of Advanced Renal Carcinoma In a Phase III…
Key Point – Aceto Pharma to acquire GMP of A&C Bio Buffer ltd Aceto will continue to support A&C BioBuffer’s manufacturing facilities and offices…
US FDA’s Center for Drug Evaluation and Research (CDER) – Novel Drug Approvals for 2021 Innovation drives progress. When it comes to…
Ind-Swift Laboratories will sell its Active Pharmaceutical Ingredients (API) business to PI Industries for an enterprise value of Rs 1,530 crore. The sale is expected…
The meeting of the 23rd WHO Expert Committee on the Selection and Use of Essential Medicines will be coordinated from WHO Headquarters, Geneva…